×

News publications and other organizations are encouraged to reuse Direct Relief-published content for free under a Creative Commons License (Attribution-Non-Commercial-No Derivatives 4.0 International), given the republisher complies with the requirements identified below.

When republishing:

  • Include a byline with the reporter’s name and Direct Relief in the following format: "Author Name, Direct Relief." If attribution in that format is not possible, include the following language at the top of the story: "This story was originally published by Direct Relief."
  • If publishing online, please link to the original URL of the story.
  • Maintain any tagline at the bottom of the story.
  • With Direct Relief's permission, news publications can make changes such as localizing the content for a particular area, using a different headline, or shortening story text. To confirm edits are acceptable, please check with Direct Relief by clicking this link.
  • If new content is added to the original story — for example, a comment from a local official — a note with language to the effect of the following must be included: "Additional reporting by [reporter and organization]."
  • If republished stories are shared on social media, Direct Relief appreciates being tagged in the posts:
    • Twitter (@DirectRelief)
    • Facebook (@DirectRelief)
    • Instagram (@DirectRelief)

Republishing Images:

Unless stated otherwise, images shot by Direct Relief may be republished for non-commercial purposes with proper attribution, given the republisher complies with the requirements identified below.

  • Maintain correct caption information.
  • Credit the photographer and Direct Relief in the caption. For example: "First and Last Name / Direct Relief."
  • Do not digitally alter images.

Direct Relief often contracts with freelance photographers who usually, but not always, allow their work to be published by Direct Relief’s media partners. Contact Direct Relief for permission to use images in which Direct Relief is not credited in the caption by clicking here.

Other Requirements:

  • Do not state or imply that donations to any third-party organization support Direct Relief's work.
  • Republishers may not sell Direct Relief's content.
  • Direct Relief's work is prohibited from populating web pages designed to improve rankings on search engines or solely to gain revenue from network-based advertisements.
  • Advance permission is required to translate Direct Relief's stories into a language different from the original language of publication. To inquire, contact us here.
  • If Direct Relief requests a change to or removal of republished Direct Relief content from a site or on-air, the republisher must comply.

For any additional questions about republishing Direct Relief content, please email the team here.

Direct Relief, Amgen, and C/Can Team Up to Improve Access to Breast Cancer Diagnostics and Treatment in Paraguay

News

Cancer

Photo by Santiago Esteban/C/Can
By Staff

Direct Relief today announced the launch of a joint, multi-year initiative with Amgen and the City Cancer Challenge (C/Can) to support breast cancer patients in Paraguay.

In coordination with C/Can, which has worked to advance equitable access to cancer diagnostics and treatment in Paraguay since 2017, Direct Relief will deliver Amgen-donated medications to specialized cancer treatment centers in Asuncion.

“Direct Relief is deeply appreciative to Amgen and C/Can for their leadership and initiative in providing equitable and quality access to these critical treatments,” said Damon Taugher, VP of global programs at Direct Relief. “Thanks to this collaboration, people who would otherwise be unable to access cancer therapies will be able to receive the treatments they need.”

In the short term, the initiative aims to establish a standardized methodology for achieving in-country readiness to support equitable and quality access to breast cancer diagnostics and medicines. It will also be reinforced with ongoing efforts to strengthen local infrastructure and the healthcare workforce in Paraguay’s leading cancer treatment institutions.

With support from Amgen, Direct Relief and C/Can will engage local stakeholders in bolstering Paraguay’s cancer care infrastructure and healthcare workforce, covering the areas of diagnosis, treatment, and palliative and supportive care.

“Our initiative with C/Can and Direct Relief can bring much-needed medicines to people suffering with cancer,” said Dr. Victoria Elegant, Global Lead, Access to Healthcare, at Amgen. “This will help achieve a sustainable improvement in the provision of cancer services and make an enduring difference.”

In short, the provision of donated medicines will be matched with quality improvements in the building blocks of Paraguay’s cancer-care health system, continuing C/Can’s work with local stakeholders to improve and sustain standards of care for breast cancer patients overall.

“By partnering with a global leader in cancer medicines like Amgen along with Direct Relief’s experience in cold chain logistics, we can ensure that the efforts that the city of Asunción has led through the C/Can initiative have strengthened the critical path to ensure that access to medicines is a sustainable, structures and measurable process and not limited to the delivery of donated medicines,” said C/Can CEO Isabel Mestres.

Filed Under: , , , ,

Giving is Good Medicine

You don't have to donate. That's why it's so extraordinary if you do.